Mylan Inc.'s subsidiary, Matrix Laboratories received final approval from the FDA for its Abbreviated New Drug Application for Lansoprazole Delayed-release.
67 WALL STREET, New York - November 13, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.
No comments:
Post a Comment